Pulmonary arterial hypertension: a look to the future.
The Third World Symposium on Pulmonary Arterial Hypertension served not only as a forum for the presentation of state-of-the art overviews of the pathobiologic and clinical aspects of pulmonary arterial hypertension (PAH), but also afforded an opportunity to the international scientific community to explore future directions of research and collaboration. This summary provides a brief overview of future directions in the field.
Rubin
Lewis J
LJ
Pulmonary Vascular Center, University of California-San Diego School of Medicine, La Jolla, California, USA. ljrubin@ucsd.edu
Galiè
Nazzareno
N
D052006:Bone Morphogenetic Protein Receptors, Type II; D005544:Forecasting; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D006976:Hypertension, Pulmonary / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D009154:Mutation / Q000235:genetics; D017063:Outcome Assessment, Health Care; D017346:Protein Serine-Threonine Kinases / Q000235:genetics; D011651:Pulmonary Artery / Q000473:pathology*
D017346:Protein Serine-Threonine Kinases; C498218:BMPR2 protein, human; D052006:Bone Morphogenetic Protein Receptors, Type II